drugset / Trial / NCT01675167

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects

NCT01675167

Phase 3 Completed 815 enrolled BioDelivery Sciences International
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-experienced subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.

Timeline

Start
2012-09
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 150 ug Other
Subject Buprenorphine Other / unclassified 900 ug Other

Indications

No indication recorded.